Detalles de la búsqueda
1.
Improving dosimetric outcome for hippocampus and cochlea sparing whole brain radiotherapy using spot-scanning proton arc therapy.
Acta Oncol
; 58(4): 483-490, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632851
2.
18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation.
Adv Radiat Oncol
; 4(4): 613-622, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31681863
3.
Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study.
Neurosurgery
; 84(3): 717-725, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29757421
4.
Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer.
Clin Transl Radiat Oncol
; 11: 1-10, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014041
5.
Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
Brachytherapy
; 17(6): 852-857, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076108
6.
Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study.
J Neurosurg
; 129(2): 383-389, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28862549
7.
Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study
J Neurosurg
; 2018 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31369225
8.
Technique of Whole-Sellar Stereotactic Radiosurgery for Cushing Disease: Results from a Multicenter, International Cohort Study.
World Neurosurg
; 116: e670-e679, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29783006
9.
Stereotactic Radiosurgery for Cushing Disease: Results of an International, Multicenter Study.
J Clin Endocrinol Metab
; 102(11): 4284-4291, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28938462
10.
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys
; 86(1): 64-71, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23462420
11.
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys
; 85(5): 1246-53, 2013 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23265567
12.
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.
Int J Radiat Oncol Biol Phys
; 83(3): 940-6, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22056069
13.
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.
Radiat Oncol
; 7: 127, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22852797
14.
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse.
Radiother Oncol
; 101(3): 513-20, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21703711
15.
The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy.
Int J Radiat Oncol Biol Phys
; 81(3): e135-42, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21345617
16.
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.
Int J Radiat Oncol Biol Phys
; 81(4): e335-44, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21645976
17.
Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy.
Int J Radiat Oncol Biol Phys
; 81(4): e361-7, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21820250
18.
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation.
Int J Radiat Oncol Biol Phys
; 81(4): e351-60, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21493015
Resultados
1 -
18
de 18
1
Próxima >
>>